Results 151 to 160 of about 92,526 (264)

<i>Pseudomonas aeruginosa</i> tRNA nucleotidyltransferase Cca controls resistance and tolerance to aminoglycoside antibiotics by regulating the MexXY multidrug efflux pump. [PDF]

Antimicrob Agents Chemother
Shen C, Wang L, Zhang Y, Zhang L, Cheng Z, Wu W, Ha U-H, Jin S, Jin Y.   +8 more
europepmc   +1 more source

Allium‐Derived Compounds Against Multidrug‐Resistant Bacteria: Antibacterial Activity and Synergistic Effects

ChemMedChem, Volume 21, Issue 8, 28 April 2026.
This study evaluates four compounds derived from the genus Allium against 330 multidrug‐resistant bacteria. Propyl‐propane‐thiosulfonate (PTSO) exhibits the highest activity, particularly against Gram‐positive strains, while Gram‐negative bacteria are less affected.
Antonio Sorlózano‐Puerto, Yariel Figueroa‐Vega, Pablo Martín‐Valenzuela, José Manuel de la Torre‐Ramírez, Alberto Baños, José Gutiérrez‐Fernández   +5 more
wiley   +1 more source

A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant <i>Pseudomonas aeruginosa</i> infections. [PDF]

Antimicrob Agents Chemother
Collings H, Stone M, Chrysostomou M, Hirst A, Waldenberg TE, Yucel E, Iodise T.   +6 more
europepmc   +1 more source

One-Day Aminoglycosides versus Three-Day Ceftazidime for Perioperative Prophylaxis and Postoperative Sepsis Risk in Patients with Urinary Calculi: A Propensity Score-Matched Retrospective Cohort Analysis. [PDF]

Drug Des Devel Ther
Sun S, Guo J, Zhang Z, Guo D, Li J, Cai X.   +5 more
europepmc   +1 more source

Glycan-binding properties of SARS-CoV-2 spike proteins: interactions with aminoglycoside antibiotics. [PDF]

Sci Rep
Hatakeyama D, Shoji M, Miki Y, Ueki S, Yamaguchi K, Nakashima K, Tanaka Y, Yokogawa M, Osawa M, Kasai Y, Imagawa H, Hashimoto R, Takayama K, Kuzuhara T.   +13 more
europepmc   +1 more source

Identification of small molecules that enhance aminoglycoside-mediated suppression of <i>CFTR</i> and <i>NF1</i> nonsense mutations. [PDF]

Mol Ther Oncol
Sammons J, Chen J, Thrasher K, Fu L, Du M, Wen H, Bostwick JR, Vinson P, Moukha-Chafiq O, Augelli-Szafran C, Keeling KM, Wallis D, Kesterson RA, Rowe SM, Bedwell DM.   +14 more
europepmc   +1 more source

Prevalence of ESBL-producing Escherichia coli from different canine populations in Italy [PDF]

, 2016
DOTTO, GIORGIA, MARTINI, MARCO, MENANDRO, MARIA LUISA, MONDIN, ALESSANDRA, PASOTTO, DANIELA, Tonellato, F. R.   +5 more
core   +1 more source

Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Karunanidhi A, Singh N, Watkins JV, Smith NM, Zang Y, Shan X, Espinoza G, Li J, Lang Y, Bulitta JB, Bulman ZP.   +10 more
europepmc   +1 more source

Bicuculline reversal of aminoglycoside O-nucleotidyltransferase EanT-1-mediated kanamycin resistance. [PDF]

BMC Microbiol
Wang J, Yu M, Zhang M, Meng Z, Yang P, Cui X, Yu Z, Wang Y, Zong G.   +8 more
europepmc   +1 more source

Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief Summary. [PDF]

Open Forum Infect Dis
Bhavnani SM, Hammel JP, Onufrak NJ, Pogue JM, Jones RN, Sader HS, Drusano GL, Bradley JS, Andes DR, Craig WA, Ambrose PG.   +10 more
europepmc   +1 more source